Identify Allergy Triggers, Optimize Treatment, & Improve Quality of Life with Clear Health Pass MDAllergyPro
Clear Health Pass MDAllergyPro is a simple allergen-specific IgE blood test used to confirm an allergy diagnosis. This form of blood testing helps assess suspected causes of symptoms, aid in allergic/nonallergic patient management, and alter the progression of allergic disease. Clear Health Pass MDAllergyPro offers allergy panels based on region, environments, trees, grasses, weeds, and common groupings of food.
A convenient and less invasive allergy test
Clear Health Pass MDAllergyPro is done with a simple blood draw, making it more convenient and less invasive for the patient. With Clear Health Pass MDAllergyPro, providers can appropriately manage their patient’sallergy symptoms, optimize patient outcomes, improve quality of life without the pain and discomfort of a traditional allergy test.
Prevelance of allergic rhinitis is estimated to range from as low as 9% to more than 40%
65% of patients taking nonsedating antihistamines were found to be nonallergic via IgE blood testing
Clear Health Pass Holdings, LLC (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.
Clear Health Pass Holdings, LLC (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.
As a Specification Developer, the Company may also arrange for the manufacturing of devices labeled with another establishment’s name by a contract manufacturer.
The distribution of collection kits, specimen transport, marketing, test distribution, and actual testing is performed by a high-complexity Clinical Laboratory Improvement Amendments (CLIA) lab.